Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective
November 07, 2026
November 07, 2026
CLEVELAND, Ohio, Nov. 7 [Category: BizHospital] -- The Cleveland Clinic posted the following news release:
* * *
Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective
*
ARO-DIMER-PA is a Dual-Target RNA Therapy that targets the liver to lower two key proteins involved in high cholesterol at the same time
CHICAGO: A new Cleveland Clinic study shows that a single dose of a ge . . .
* * *
Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective
*
ARO-DIMER-PA is a Dual-Target RNA Therapy that targets the liver to lower two key proteins involved in high cholesterol at the same time
CHICAGO: A new Cleveland Clinic study shows that a single dose of a ge . . .